SRNEQ
Price
$0.31
Change
-$0.00 (-0.00%)
Updated
Feb 22, 6:59 PM EST
3 days until earnings call
TNXP
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Feb 23, 6:59 PM EST
Ad is loading...

Analysis and predictions SRNEQ vs TNXP

Header iconSRNEQ vs TNXP Comparison
Open Charts SRNEQ vs TNXPBanner chart's image
Sorrento Therapeutics
Price$0.31
Change-$0.00 (-0.00%)
Volume$77.42M
CapitalizationN/A
Tonix Pharmaceuticals Holding
Price$0.32
Change-$0.00 (-0.00%)
Volume$612.96K
CapitalizationN/A
View a ticker or compare two or three
SRNEQ vs TNXP Comparison Chart

Loading...

SRNEQDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TNXPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
SRNEQ vs. TNXP commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRNEQ is a Hold and TNXP is a Hold.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (SRNEQ: $0.10 vs. TNXP: $0.32)
Brand notoriety: SRNEQ: Notable vs. TNXP: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRNEQ: 18% vs. TNXP: 49%
Market capitalization -- SRNEQ: $179.17M vs. TNXP: $18.87M
SRNEQ [@Biotechnology] is valued at $179.17M. TNXP’s [@Biotechnology] market capitalization is $18.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRNEQ’s FA Score shows that 1 FA rating(s) are green whileTNXP’s FA Score has 1 green FA rating(s).

  • SRNEQ’s FA Score: 1 green, 4 red.
  • TNXP’s FA Score: 1 green, 4 red.
According to our system of comparison, SRNEQ is a better buy in the long-term than TNXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRNEQ’s TA Score shows that 5 TA indicator(s) are bullish while TNXP’s TA Score has 5 bullish TA indicator(s).

  • SRNEQ’s TA Score: 5 bullish, 5 bearish.
  • TNXP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TNXP is a better buy in the short-term than SRNEQ.

Price Growth

SRNEQ (@Biotechnology) experienced а +253.57% price change this week, while TNXP (@Biotechnology) price change was -15.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

SRNEQ is expected to report earnings on May 07, 2024.

TNXP is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for SRNEQ with price predictions.
OPEN
A.I.dvisor published
a Summary for TNXP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SRNEQ($179M) has a higher market cap than TNXP($18.9M). SRNEQ (-19.838) and TNXP (-20.099) have similar YTD gains . TNXP has higher annual earnings (EBITDA): -119.91M vs. SRNEQ (-645.56M). SRNEQ has more cash in the bank: 50.3M vs. TNXP (6.91M). TNXP has less debt than SRNEQ: TNXP (1.15M) vs SRNEQ (170M). SRNEQ has higher revenues than TNXP: SRNEQ (60.7M) vs TNXP (3.99M).
SRNEQTNXPSRNEQ / TNXP
Capitalization179M18.9M947%
EBITDA-645.56M-119.91M538%
Gain YTD-19.838-20.09999%
P/E RatioN/AN/A-
Revenue60.7M3.99M1,522%
Total Cash50.3M6.91M728%
Total Debt170M1.15M14,783%
FUNDAMENTALS RATINGS
SRNEQ vs TNXP: Fundamental Ratings
SRNEQ
TNXP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNXP's Valuation (9) in the Pharmaceuticals Other industry is in the same range as SRNEQ (23) in the Biotechnology industry. This means that TNXP’s stock grew similarly to SRNEQ’s over the last 12 months.

TNXP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as SRNEQ (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to SRNEQ’s over the last 12 months.

TNXP's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as SRNEQ (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to SRNEQ’s over the last 12 months.

SRNEQ's Price Growth Rating (34) in the Biotechnology industry is in the same range as TNXP (65) in the Pharmaceuticals Other industry. This means that SRNEQ’s stock grew similarly to TNXP’s over the last 12 months.

SRNEQ's P/E Growth Rating (100) in the Biotechnology industry is in the same range as TNXP (100) in the Pharmaceuticals Other industry. This means that SRNEQ’s stock grew similarly to TNXP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRNEQTNXP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 5 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
SRNEQDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TNXPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TROW110.990.09
+0.08%
T Rowe Price Group
MBOT1.26-0.01
-0.69%
Microbot Medical
ESCA15.33-0.34
-2.17%
Escalade
LAZR2.19-0.11
-4.78%
Luminar Technologies
SATS12.67-0.65
-4.88%
EchoStar Corp

SRNEQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRNEQ has been closely correlated with SGMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SRNEQ jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRNEQ
1D Price
Change %
SRNEQ100%
+164.00%
SGMO - SRNEQ
73%
Closely correlated
+2.73%
GTHX - SRNEQ
64%
Loosely correlated
+3.26%
AGEN - SRNEQ
63%
Loosely correlated
+1.05%
CHRS - SRNEQ
60%
Loosely correlated
+4.45%
TECH - SRNEQ
57%
Loosely correlated
-0.20%
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been loosely correlated with TOVX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if TNXP jumps, then TOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
+1.77%
TOVX - TNXP
35%
Loosely correlated
-5.28%
CRVS - TNXP
32%
Poorly correlated
+1.73%
SRNEQ - TNXP
29%
Poorly correlated
+164.00%
EIGR - TNXP
28%
Poorly correlated
-6.72%
RNAZ - TNXP
28%
Poorly correlated
-5.30%
More